UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 124

Sortiert nach

DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation

Modern pathology, 2019-02, Vol.32 (2), p.280-289

2019

Volltextzugriff (PDF)

BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program

Science (American Association for the Advancement of Science), 2010-12, Vol.330 (6009), p.1390-1393

2010

Volltextzugriff (PDF)

Uterine Inflammatory Myofibroblastic Tumors: Proposed Risk Stratification Model Using Integrated Clinicopathologic and Molecular Analysis

The American journal of surgical pathology, 2023-02, Vol.47 (2), p.157

2023

Volltextzugriff (PDF)

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Nature communications, 2020-11, Vol.11 (1), p.5824-15, Article 5824

2020

Volltextzugriff (PDF)

Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis

Modern pathology, 2020-08, Vol.33 (8), p.1518-1526

2020

Volltextzugriff (PDF)

PUMA and BIM are required for oncogene inactivation-induced apoptosis

Science signaling, 2013-03, Vol.6 (268), p.ra20

2013

Volltextzugriff (PDF)

NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma

Histopathology, 2020-07, Vol.77 (1), p.100-111

2020

Volltextzugriff (PDF)

Fibroepithelial Lesions; The WHO Spectrum

Seminars in diagnostic pathology, 2017-09, Vol.34 (5), p.438-452

2017

Volltextzugriff (PDF)

PDGFB RNA in situ hybridization for the diagnosis of dermatofibrosarcoma protuberans

Modern pathology, 2021-08, Vol.34 (8), p.1521-1529

2021

Volltextzugriff (PDF)

Transcriptional and Immune Landscape of Cardiac Sarcoidosis

Circulation research, 2022-09, Vol.131 (8), p.654-669

2022

Volltextzugriff (PDF)

Contemporary diagnostic approach to atypical vascular lesion and angiosarcoma

Seminars in diagnostic pathology, 2023-07, Vol.40 (4), p.284-294

2023

Volltextzugriff (PDF)

Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast

The American journal of surgical pathology, 2019-12, Vol.43 (12), p.1693

2019

Volltextzugriff (PDF)

Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics

Human pathology, 2023-09, Vol.139, p.17-26

2023

Volltextzugriff (PDF)

Recurrent GNAQ mutations in anastomosing hemangiomas

Modern pathology, 2017-05, Vol.30 (5), p.722-727

2017

Volltextzugriff (PDF)

Molecular Testing in Breast Cancer: Current Status and Future Directions

The Journal of molecular diagnostics : JMD, 2021-11, Vol.23 (11), p.1422-1432

2021

Volltextzugriff (PDF)

Targeted DNA sequencing in diagnosis of malignant phyllodes tumors with emphasis on tumors with keratin and p63 expression

Modern pathology, 2024-08, p.100593

2024

Volltextzugriff (PDF)

Synchronous Breast Implant–associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications

Plastic and reconstructive surgery. Global open, 2019-04, Vol.7 (4), p.e2188-e2188

2019

Volltextzugriff (PDF)

Wilms Tumor: An Unexpected Diagnosis in Adult Patients

Archives of pathology & laboratory medicine (1976), 2024-06, Vol.148 (6), p.722-727

2024

Volltextzugriff (PDF)

Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas

Modern pathology, 2017-08, Vol.30 (8), p.1086-1099

2017

Volltextzugriff (PDF)

Nodular fasciitis of the breast: clinicopathologic and molecular characterization with identification of novel USP6 fusion partners

Modern pathology, 2021-10, Vol.34 (10), p.1865-1875

2021

Volltextzugriff (PDF)

Skin angiography assisted mastectomy in secondary breast angiosarcoma: Complete clinical response after neoadjuvant immunotherapy

The breast journal, 2021-09, Vol.27 (9), p.723-725

2021

Volltextzugriff (PDF)

CpG Island Tumor Suppressor Promoter Methylation in Non-BRCA-Associated Early Mammary Carcinogenesis

Cancer epidemiology, biomarkers & prevention, 2009-03, Vol.18 (3), p.901-914

2009

Volltextzugriff (PDF)

Recurrent GNA14 mutations in anastomosing haemangiomas

Histopathology, 2018-08, Vol.73 (2), p.354-357

2018

Volltextzugriff (PDF)

Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection

Clinical cancer research, 2020-05, Vol.26 (9), p.2140-2150

2020

Volltextzugriff (PDF)

Genetic and Immunohistochemical Profiling of Mammary Hidradenoma and Comparison to Mucoepidermoid Carcinoma

Modern pathology, 2023-10, Vol.36 (10), p.100270-100270, Article 100270

2023

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(124)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation

BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program

Uterine Inflammatory Myofibroblastic Tumors: Proposed Risk Stratification Model Using Integrated Clinicopathologic and Molecular Analysis

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis

PUMA and BIM are required for oncogene inactivation-induced apoptosis

NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma

Fibroepithelial Lesions; The WHO Spectrum

PDGFB RNA in situ hybridization for the diagnosis of dermatofibrosarcoma protuberans

Transcriptional and Immune Landscape of Cardiac Sarcoidosis

Contemporary diagnostic approach to atypical vascular lesion and angiosarcoma

Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast

Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics

Recurrent GNAQ mutations in anastomosing hemangiomas

Molecular Testing in Breast Cancer: Current Status and Future Directions

Targeted DNA sequencing in diagnosis of malignant phyllodes tumors with emphasis on tumors with keratin and p63 expression

Synchronous Breast Implant–associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications

Wilms Tumor: An Unexpected Diagnosis in Adult Patients

Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas

Nodular fasciitis of the breast: clinicopathologic and molecular characterization with identification of novel USP6 fusion partners

Skin angiography assisted mastectomy in secondary breast angiosarcoma: Complete clinical response after neoadjuvant immunotherapy

CpG Island Tumor Suppressor Promoter Methylation in Non-BRCA-Associated Early Mammary Carcinogenesis

Recurrent GNA14 mutations in anastomosing haemangiomas

Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection

Genetic and Immunohistochemical Profiling of Mammary Hidradenoma and Comparison to Mucoepidermoid Carcinoma

Suchergebnisse filtern